Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

USA - NASDAQ:DORM - US2582781009 - Common Stock

156.44 USD
-2.56 (-1.61%)
Last: 9/19/2025, 4:30:01 PM
156.44 USD
0 (0%)
After Hours: 9/19/2025, 4:30:01 PM
Fundamental Rating

7

DORM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 80 industry peers in the Automobile Components industry. DORM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, DORM is valued expensive at the moment. This makes DORM very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

DORM had positive earnings in the past year.
DORM had a positive operating cash flow in the past year.
Each year in the past 5 years DORM has been profitable.
In the past 5 years DORM always reported a positive cash flow from operatings.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

With an excellent Return On Assets value of 9.14%, DORM belongs to the best of the industry, outperforming 96.25% of the companies in the same industry.
The Return On Equity of DORM (16.14%) is better than 93.75% of its industry peers.
DORM has a better Return On Invested Capital (12.70%) than 93.75% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DORM is in line with the industry average of 8.51%.
The 3 year average ROIC (9.34%) for DORM is below the current ROIC(12.70%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROIC 12.7%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

DORM's Profit Margin of 10.83% is amongst the best of the industry. DORM outperforms 97.50% of its industry peers.
DORM's Profit Margin has improved in the last couple of years.
DORM's Operating Margin of 15.75% is amongst the best of the industry. DORM outperforms 98.75% of its industry peers.
DORM's Operating Margin has improved in the last couple of years.
DORM's Gross Margin of 40.88% is amongst the best of the industry. DORM outperforms 93.75% of its industry peers.
In the last couple of years the Gross Margin of DORM has grown nicely.
Industry RankSector Rank
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DORM is still creating some value.
Compared to 1 year ago, DORM has less shares outstanding
The number of shares outstanding for DORM has been reduced compared to 5 years ago.
Compared to 1 year ago, DORM has an improved debt to assets ratio.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 5.17 indicates that DORM is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.17, DORM belongs to the best of the industry, outperforming 86.25% of the companies in the same industry.
The Debt to FCF ratio of DORM is 3.31, which is a good value as it means it would take DORM, 3.31 years of fcf income to pay off all of its debts.
DORM has a Debt to FCF ratio of 3.31. This is amongst the best in the industry. DORM outperforms 91.25% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that DORM is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.31, DORM belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Altman-Z 5.17
ROIC/WACC1.31
WACC9.72%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

DORM has a Current Ratio of 2.74. This indicates that DORM is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of DORM (2.74) is better than 85.00% of its industry peers.
A Quick Ratio of 1.21 indicates that DORM should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.21, DORM is doing good in the industry, outperforming 71.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 1.21
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.49% over the past year.
DORM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.83% yearly.
The Revenue has been growing slightly by 6.76% in the past year.
DORM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.18% yearly.
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%

3.2 Future

DORM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.80% yearly.
DORM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.18% yearly.
EPS Next Y21.23%
EPS Next 2Y12.56%
EPS Next 3YN/A
EPS Next 5Y7.8%
Revenue Next Year8.58%
Revenue Next 2Y6.94%
Revenue Next 3Y6.53%
Revenue Next 5Y6.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.99, DORM is valued on the expensive side.
The rest of the industry has a similar Price/Earnings ratio as DORM.
When comparing the Price/Earnings ratio of DORM to the average of the S&P500 Index (27.41), we can say DORM is valued slightly cheaper.
DORM is valuated rather expensively with a Price/Forward Earnings ratio of 17.29.
Based on the Price/Forward Earnings ratio, DORM is valued a bit more expensive than 63.75% of the companies in the same industry.
DORM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.88.
Industry RankSector Rank
PE 18.99
Fwd PE 17.29
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DORM is valued a bit more expensive than the industry average as 71.25% of the companies are valued more cheaply.
61.25% of the companies in the same industry are cheaper than DORM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 34.28
EV/EBITDA 13.67
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

DORM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DORM has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as DORM's earnings are expected to grow with 12.56% in the coming years.
PEG (NY)0.89
PEG (5Y)0.87
EPS Next 2Y12.56%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for DORM!.
Industry RankSector Rank
Dividend Yield N/A

DORMAN PRODUCTS INC

NASDAQ:DORM (9/19/2025, 4:30:01 PM)

After market: 156.44 0 (0%)

156.44

-2.56 (-1.61%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners86.17%
Inst Owner Change1.82%
Ins Owners10.8%
Ins Owner Change0.28%
Market Cap4.78B
Analysts81.67
Price Target166.6 (6.49%)
Short Float %3.37%
Short Ratio4.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.85%
Min EPS beat(2)11.58%
Max EPS beat(2)36.11%
EPS beat(4)4
Avg EPS beat(4)20.79%
Min EPS beat(4)9.67%
Max EPS beat(4)36.11%
EPS beat(8)7
Avg EPS beat(8)21.58%
EPS beat(12)7
Avg EPS beat(12)9.41%
EPS beat(16)8
Avg EPS beat(16)6.6%
Revenue beat(2)2
Avg Revenue beat(2)3.13%
Min Revenue beat(2)2.92%
Max Revenue beat(2)3.34%
Revenue beat(4)2
Avg Revenue beat(4)0.7%
Min Revenue beat(4)-3.19%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.75%
Revenue beat(12)3
Avg Revenue beat(12)-0.64%
Revenue beat(16)7
Avg Revenue beat(16)0.63%
PT rev (1m)12.06%
PT rev (3m)12.06%
EPS NQ rev (1m)19.84%
EPS NQ rev (3m)34.58%
EPS NY rev (1m)8.73%
EPS NY rev (3m)8.73%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)5.44%
Revenue NY rev (1m)3.65%
Revenue NY rev (3m)3.65%
Valuation
Industry RankSector Rank
PE 18.99
Fwd PE 17.29
P/S 2.29
P/FCF 34.28
P/OCF 27.21
P/B 3.41
P/tB 6.95
EV/EBITDA 13.67
EPS(TTM)8.24
EY5.27%
EPS(NY)9.05
Fwd EY5.78%
FCF(TTM)4.56
FCFY2.92%
OCF(TTM)5.75
OCFY3.67%
SpS68.33
BVpS45.85
TBVpS22.52
PEG (NY)0.89
PEG (5Y)0.87
Profitability
Industry RankSector Rank
ROA 9.14%
ROE 16.14%
ROCE 16.84%
ROIC 12.7%
ROICexc 13.08%
ROICexgc 20.96%
OM 15.75%
PM (TTM) 10.83%
GM 40.88%
FCFM 6.68%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexcg growth 3Y8.15%
ROICexcg growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 3.31
Debt/EBITDA 1.12
Cap/Depr 64.28%
Cap/Sales 1.73%
Interest Coverage 10.99
Cash Conversion 45.61%
Profit Quality 61.66%
Current Ratio 2.74
Quick Ratio 1.21
Altman-Z 5.17
F-Score7
WACC9.72%
ROIC/WACC1.31
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)38.49%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%23.35%
EPS Next Y21.23%
EPS Next 2Y12.56%
EPS Next 3YN/A
EPS Next 5Y7.8%
Revenue 1Y (TTM)6.76%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.56%
Revenue Next Year8.58%
Revenue Next 2Y6.94%
Revenue Next 3Y6.53%
Revenue Next 5Y6.18%
EBIT growth 1Y22.22%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year26.36%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y167.44%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y80.56%
OCF growth 3Y32.07%
OCF growth 5Y19.38%